Exact Sciences, a cancer screening and diagnostic test provider, is expecting to report revenue between $550.7 and $552.7 million for the fourth quarter, according to a Jan. 8 release.
Exact Sciences expects $550M in revenue in Q4: 5 things to know
Exact Sciences, a cancer screening and diagnostic test provider, is expecting to report revenue between $550.7 and $552.7 million for the fourth quarter, according to a Jan. 8 release.